´ëÇѴٹ߼º°æÈÁõÇÐȸ 2019³â º¸¼ö±³À° : 2019-02-23±³À°ÀÏÀÚ : 2019-02-23
±³À°Àå¼Ò : The K Hotel º»°ü 3Ãþ ºñÆÄȦ
±³À°ÁÖÁ¦ :
´ëÇѴٹ߼º°æÈÁõÇÐȸ 2019³â º¸¼ö±³À°ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѴٹ߼º°æÈÁõÇÐȸ
´ã´çÀÚ : ´ëÇѴٹ߼º°æÈÁõÇÐȸ
¿¬¶ôó : 02-720-1594
À̸ÞÀÏ :
ksms1594@hanmail.net ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 40,000¿ø
ºñ°í »çÀüµî·Ï: Àü°øÀÇ 1¸¸¿ø, Àü¹®ÀÇ 2¸¸¿ø, ±âŸ:3¸¸¿ø / ´çÀϵî·Ï: Àü°øÀÇ 1¸¸¿ø, Àü¹®ÀÇ 3¸¸¿ø, ±âŸ: 4¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02-23 ´õÄÉÀÌÈ£ÅÚ º»°ü3Ãþ ºñÆÄȦ 13:10~13:40 The diagnosis of MS: From MAGNIMS 2016 to the 2017 revision of the McDonald criteria ±èÁöÀº(¼¿ïÀÇ·á¿ø)
±³À°½Ã°£ 02-23 ´õÄÉÀÌÈ£ÅÚ º»°ü3Ãþ ºñÆÄȦ 13:40~14:10 Serum and CSF biomarker in MS ³²Å½Â(Àü³²ÀÇ´ë)
±³À°½Ã°£ 02-23 ´õÄÉÀÌÈ£ÅÚ º»°ü3Ãþ ºñÆÄȦ 14:10~14:40 Treatment selection and switching in MS ±è¼öÇö(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 02-23 ´õÄÉÀÌÈ£ÅÚ º»°ü3Ãþ ºñÆÄȦ 15:00~15:30 MNOSD: concept in evolution °»çÀ±(Á¦ÁÖÀÇ´ë)
±³À°½Ã°£ 02-23 ´õÄÉÀÌÈ£ÅÚ º»°ü3Ãþ ºñÆÄȦ 15:30~16:00 Treatment of NMOSD using case studies ±è¿ìÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02-23 ´õÄÉÀÌÈ£ÅÚ º»°ü3Ãþ ºñÆÄȦ 16:00~16:30 MOG antibody disease update and differentiation from MS and MNOSD ±è¼º¹Î(¼¿ïÀÇ´ë)